Results

Total Results: 1,528 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - and telaprevir (trade name Incivek®), for treatment of chronic HCV genotype 1 infection.24,25 Both drugs … Packets on unpublished and published trials were solicited from manufacturers of included antiviral drugs … their effects would be helpful for guiding health care providers’ treatment choices between these drugs … Third, few trials have evaluated the regimens approved specifically by the FDA for these drugs, limiting … are currently in active development, and further studies with new drugs and drug regimens are expected
  2. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
    February 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … targeting pathways and processes hypothesized to underlie AD-related cognitive decline, neuroprotective pharmaceuticals … CNS Drugs. 2013 Jul;27(7):505-14.
  3. effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research
  4. Title (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-adults-prisons_research-protocol.pdf
    September 13, 2012 - lower risk for developing movement disorders and other unpleasant side effects, but some of these drugs … in most prison formularies for treating bipolar disorder and schizoaffective disorder because these drugs … Drug therapy/ Exp antidepressive agents/ Psychotropic drugs/ Therapeutic use.fs. … OR exp neuroleptic agent/ OR exp neuroleptic drugs/ OR psychopharmacotherapy/ OR psychotropic agent … / OR psychotropic drugs/ 8 Pharmacologic interventions Text words (drug ADJ (based OR counseling
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-evidence-reviews-federal-agencies.pdf
    July 01, 2020 - These reviews focus on a variety of issues, including comparing clinical drugs or treatments, and interventions
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
    November 01, 2014 - hospital-acquired pneumonia. 4 Optimal treatment involves choosing the right drug or combination of drugs … During the same period, the number of new antibiotics developed has decreased, especially for drugs … toxicities.19 With fewer antibiotic options, ensuring the appropriate and judicious use of these drugs … infection more rapidly and accurately, public policies to support development and approval of new drugs … Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis. 2009 Sep 15;49(6):992-3.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
    January 15, 2015 - The antihypertensive agents, lipid-lowering drugs, and antiplatelet agents are all FDA approved for … The risks and adverse events of the drugs are well-understood and include symptomatic hypotension, myalgia … therapy, including “aggressive medical therapy” (antihypertensive, antiplatelet, and lipid-lowering drugs … Categorical (eg, better/worse) o Continuous BP o Medication need (eg, number of antihypertensive drugs
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
    July 01, 2016 - Treatments typically follow a progression from less invasive nonsurgical interventions (dietary fiber, drugs … Nonsurgical treatments include dietary fiber supplementation, bowel schedules, stool-modifying drugs
  9. S1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
    October 01, 2007 - health of many Americans as well as the effectiveness of nearly all other health care services in which pharmaceuticals … As the federal government becomes a major payer of prescription drugs while also providing insurance
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - Pregabalin/ gabapentin versus duloxetine short- term No difference between drugs • SOE: Insufficient … 83 Conclusions A systematic review and three subsequent surveillance updates have found nonopioid drugs … Nonopioid drugs were associated with increased risk of class-specific harms (e.g., gastrointestinal … vivo effects of nonselective, partially selective, and selective non steroidal anti- inflammatory drugs … Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - Key Messages • As initial therapy in the prehospital setting: – Nonsteroidal anti-inflammatory drugs … including ketamine, acetaminophen (APAP), nitrous oxide/oxygen and nonsteroidal anti-inflammatory drugs … Versus Opioid Opioids Versus APAP Opioids Versus Nitrous Oxide Opioids Versus NSAIDs Specific drugs … =intranasal; IV=intravenous; NEB=nebulized; NR=not reported; NSAIDs=nonsteroidal anti-inflammatory drugs
  12. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - other drugs). … We made a note of this in Table 2, where the drugs are first described. … Provide the names of the specific drugs, as in Table 51 on the next page. … Same issue, provide the names of specific drugs. … Incretinbased drugs and the risk of congestive heart failure.
  13. effectivehealthcare.ahrq.gov/products/grant-manuscripts/rapid-network-abstract
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - Pharmacological treatment is generally reserved for patients with severe RLS. 11 The major classes of drugs … nicotine; antidepressants; antihistamines) †Adverse effects of treatments are specific to use of these drugs … We do not know the impact of long-term use of these drugs in children. … Neither do we know the risks/benefits of the drugs for older adults who take several medications for … All reported adverse reactions and effects including Augmentation (Harms specific to each class of drugs
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - Pomona, NY: Duramed Pharmaceuticals, Inc.; 2009. 83. Nordette [package insert]. … Wayne, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2012. 86. … Wayne, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2009. 92. FDA. … Morgantown, WV: Mylan Pharmaceuticals, Inc.; 2006. 106. Naprosyn [package insert]. … Nonsteroidal anti- inflammatory drugs for dysmenorrhoea.
  16. effectivehealthcare.ahrq.gov/sites/default/files/introduction-user-guide-to-ocer_130129.pdf
    April 26, 2012 - In addition, new drugs and other interventions often lack comparative efficacy data to quantify a therapy … obstructive pulmonary disease,13 carotid revascularization among Medicare beneficiaries,14 prescription drugs … ADHD drugs and serious cardiovascular events in children and young adults.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
    December 06, 2010 - Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … Simponi® Tocililizumab Actemra®, RoActemrai® • Comparators: All key questions: all review drugs
  18. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Available: http://www.cesar.umd.edu/cesar/drugs/ketamine. pdf. 4. … CNS Drugs. 2012 Mar 1;26(3):189-204. … PMID: 23200737 http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http://www.cesar.umd.edu/cesar/drugs … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
    June 20, 2013 - joint steroid injection, intradiscal methylene blue, intradiscal ozone, injections involving anti-TNF drugs
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - focused on the outcomes, effectiveness, comparative clinical effectiveness, and appropriateness of pharmaceuticals … evaluate outcomes for diverse purposes ranging from the natural history of a disease, to the safety of drugs … focused on the outcomes, effectiveness, comparative clinical effectiveness, and appropriateness of pharmaceuticals … AEs are categorized according to the seriousness and, for drugs, the expectedness of the event. … If the registry receives sponsorship, in whole or in part, from a regulated industry (for drugs or devices

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: